MIAMI, Jan. 25, 2005 (PRIMEZONE) -- Stock Market Alert's watch list includes: Southwestern Medical Solutions Inc. (Pink Sheets:SWNM), General Electric Company (NYSE:GE), Pharmos Corporation (Nasdaq:PARS) and EMC Corporation (NYSE:EMC).
Southwestern Medical Solutions, Inc. (Pink Sheets:SWNM) issued a press release that may get investor's attention. Late yesterday afternoon, the company announced that, as the final stages of development of Design 1 Labguard(tm) systems nears completion, it has already begun design analysis and discussions with manufacturing to develop its Design 2 Labguard(tm), which will facilitate an even broader array of tests to be conducted with a single device. Before the news was released, the company's stock closed at thirty cents a share.
The press release stated that Mr. Gene Warner, owner of several diagnostic testing facilities in the South, has made the following comments regarding Labguard and its impending market launch; "The Labguard(tm) will bring to market a more affordable means of diagnostic testing with advancements that should render many of the current modalities obsolete. This is a simple and safe device and we will implement it into our entire system immediately upon its availability."
During preparations for the launch of this first generation product, SWNM has been in contact with many suppliers to major U.S. and international medical corporations and has been met with open arms. SWNM carried out independent research with hundreds of caregivers, diagnostic testing facilities and large distributors to determine the needs for the stage 1 and stage 2 Labguard(tm) product lines. Due to the increased capabilities of the manufacturing and prototyping processes, the stage 2 product launch will follow the launch of the stage 1 product by only a few short months.
Southwestern Medical Has The Solution -- The Company's proprietary Labguard system for on-site collection & diagnostic testing technology represents a revolutionary approach that ensures greater safety and convenience for diagnostic testing administrators at an attractive, market-competitive price. Currently in the final prototype stage, the Labguard system has already attracted expressions of strong interest from several major medical-device distribution companies, both in the U.S. and abroad. Numerous applications of the Labguard system to address specific market needs, such as non-invasive drug screening, HIV testing, etc. are currently in the design, prototype and/or testing stages.
Other stocks of interest yesterday were: General Electric Company (NYSE:GE) up 0.3% on 22.6 million shares traded, Pharmos Corporation (Nasdaq:PARS) up 1.7% on 7.2 million shares traded and EMC Corporation (NYSE:EMC) down 1.9% on 12.8 million shares traded.
The release is provided by Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company". The company received compensation for services performed for Southwestern Medical Solutions, Inc. (SWNM). The compensation is fifty nine thousand dollars from non-affiliated third party, Alex Consulting Inc. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.
The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.
The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.
Investing in the public company that this release is providing service for should be reviewed is speculative and a high-risk and may result in the loss of some or all of any investment.
This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.